---
title: "WORK Medical Technology Group Is Trending Overnight — Here's Why WOK Stock Surged Over 69% In After-Hours Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286203998.md"
description: "WORK Medical Technology Group Ltd. shares surged 69.67% in after-hours trading following a strategic cooperation agreement with Shanghai Novabioplus Biotechnology. The agreement focuses on AI-driven biotech and the development of a BioToken framework, marking a significant shift for WORK from device manufacturing to building a life sciences digital ecosystem. Despite the surge, the stock has dropped 99.88% over the past year, indicating ongoing risks and the need for signs of recovery."
datetime: "2026-05-13T05:34:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286203998.md)
  - [en](https://longbridge.com/en/news/286203998.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286203998.md)
---

# WORK Medical Technology Group Is Trending Overnight — Here's Why WOK Stock Surged Over 69% In After-Hours Session

**WORK Medical Technology Group Ltd.** (NASDAQ:WOK) shares are trending on Wednesday.

WOK shares spiked 69.67% to $11.30 in after-hours trading on Tuesday after the Hangzhou-based medical device supplier disclosed a strategic cooperation agreement with **Shanghai Novabioplus Biotechnology Co., Ltd.**, a provider of biological reagent products and solutions.

## WOK Eyes Evolution Beyond Device Manufacturing

According to WORK Medical’s Monday announcement, the pact was signed on Apr. 13 and targets the development of a “Data-Model-Application” trinity of next-generation intelligent medical models.

The deal is centered on a "**BioToken**" framework that, similar to the company's existing medical real-world assets (RWA) model, converts biopharmaceutical R&D outputs into verifiable and measurable digital assets. The roadmap is anchored by four core "AI+" projects, including membrane protein design, antibody sequence optimization, enzyme molecule design and peptide design.

Management called the agreement “a significant milestone” in WOK’s evolution from a high-end medical device manufacturer into a “life sciences digital ecosystem builder.”

## Trading Metrics, Technical Analysis

WORK Medical has a market capitalization of $11.49 million, a 52-week high of $10,800 and a 52-week low of $0.19.

The Relative Strength Index (RSI) of WOK stands at 89.46.

The small-cap stock has dropped 99.88% over the past 12 months.

Currently, WOK is positioned very close to the bottom of its 52-week range.

The stock's sharp decline and weak positioning suggest continued pressure, highlighting higher risk and the need for clear signs of recovery before investor confidence returns.

**Price Action:** WOK closed the regular session up 69.90% at $6.66, according to Benzinga Pro.

**Benzinga's Edge Stock Rankings** indicate that WOK is experiencing long-term consolidation along with medium and short-term upward movement.

_Photo Courtesy: Zakharchuk on Shutterstock.com_

**Disclaimer:** This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

**Read Also: QuantumScape (QS) Stock Is Trending Overnight: What's Going On?**

### Related Stocks

- [WOK.US](https://longbridge.com/en/quote/WOK.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [SSTK.US](https://longbridge.com/en/quote/SSTK.US.md)
- [QS.US](https://longbridge.com/en/quote/QS.US.md)

## Related News & Research

- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)
- [Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 | WVE Stock News](https://longbridge.com/en/news/286925108.md)
- [Altimetrik Recognized in 3 Categories in ISG Provider Lens™ 2026 for Life Sciences Digital Services](https://longbridge.com/en/news/286893708.md)
- [16:52 ETNexusTek Named a Contender in ISG Provider Lens® Life Sciences Digital Services 2026 Report](https://longbridge.com/en/news/286818120.md)